Painreform Ltd. financial data

Symbol
PRFX on Nasdaq
Industry
Pharmaceutical Preparations
Location
65 Yigal Alon St., Tel Aviv, Israel
State of incorporation
Israel
Fiscal year end
December 31
Latest financial report
20-F - Q4 2023 - Feb 29, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.73M shares -83.7%
Common Stock, Shares, Outstanding 3.47M shares +218%
Common Stock, Value, Issued 288K USD +206%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.78M USD -45.8%
Assets, Current 2.99M USD -63.9%
Property, Plant and Equipment, Net 42K USD +10.5%
Operating Lease, Right-of-Use Asset 73K USD
Assets 3.11M USD -62.6%
Employee-related Liabilities, Current 440K USD -12.2%
Accrued Liabilities, Current 4.28M USD +714%
Liabilities, Current 4.89M USD +346%
Operating Lease, Liability, Noncurrent 2K USD
Liabilities 5.15M USD +283%
Retained Earnings (Accumulated Deficit) -54.7M USD -47.8%
Stockholders' Equity Attributable to Parent -2.04M USD -129%
Liabilities and Equity 3.11M USD -62.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 20M shares +300%
Common Stock, Shares, Issued 3.47M shares +218%
Common Stock, Par or Stated Value Per Share 0.3 ILS/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.79M USD -45.7%
Deferred Tax Assets, Valuation Allowance 6.93M USD +28.8%
Operating Lease, Liability, Current 57K USD
Deferred Tax Assets, Operating Loss Carryforwards 5.7M USD +25.8%
Unrecognized Tax Benefits 255K USD +3.24%
Additional Paid in Capital 52.4M USD +19.3%
Deferred Tax Assets, Net of Valuation Allowance 0 USD